Visalytics
Visalytics
approved EB-2 (NIW)

Researcher V

Biomedical Science · India · 2025-04-02

Processing Time
58 days
Decision Date
2025-04-02
Location
Alabama
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in cancer immunology with a specific focus on the pancreatic cancer tumor microenvironment and immune modulation. Her work aims to develop methods that synergize with immunotherapies and chemotherapies to enhance treatment efficacy and improve patient outcomes. She intends to continue publishing high-impact research to advance the field of biomedical science in the United States.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses pancreatic cancer treatment and immune evasion, which is supported by the U.S. Department of Defense.

2 Well-positioned to Advance the Endeavor Met

The petitioner holds a Ph.D. and has a significant record of publications, citations, and peer review contributions.

3 Balance of Interests Met

The novelty of the research and its potential to improve patient outcomes make it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 12 peer-reviewed journal articles, 23 conference abstracts, and 1 book chapter, which accumulated 222 citations. Her work was supported by funding from the U.S. Department of Defense and included evidence of 20 peer reviews for high-ranking journals. Two expert recommendation letters further validated the novelty and national importance of her contributions to pancreatic cancer immunotherapy.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Conference Presentations
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Research Fellow

Biotechnology · China

WeGreened EB-2 (NIW) approved
Michigan 633 days 2025-10-20
The petitioner proposes to continue his research into the molecular and pathological processes underlying pancreatic cancer development to identify novel biomarkers and therapeutic targets. His work utilizes molecular and translational studies to bridge the gap between molecular biology and clinical research for improved cancer management. The endeavor aims to address high mortality rates in oncology by facilitating more effective medical interventions and precision medicine.
View Case

Research Assistant

Biotechnology · Malaysia

WeGreened EB-2 (NIW) approved
New York 5 days 2025-03-08
The petitioner proposes to uncover molecular and intercellular vulnerabilities in malignant tumors to combat treatment resistance, metastasis, and immune evasion. Her work specifically focuses on pancreatic ductal adenocarcinoma (PDAC) progression by examining how tumor and stromal cells interact and co-evolve using genome editing and transcriptomic profiling.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 467 days 2025-02-25
The petitioner proposes to continue identifying and characterizing novel genes and pathways that influence tumor cell behavior. Her work focuses on improving the understanding of cancer pathogenesis and immunotherapy to accelerate the development of new therapeutic strategies.
View Case

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
New Jersey 180 days 2025-09-03
The petitioner proposes to combine molecular biology methods with innovative drug delivery systems to enhance immune recognition of cancer cells. Her work focuses on developing next-generation immunotherapies that provide highly effective and less toxic treatment options for patients.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-02.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 58 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist